Stock prices
Mid Pharma Industries, a pharmaceutical company trading under the symbol MPHA at the Amman Stock Exchange, witnessed a substantial shift in its stock price on August 28, 2025. The stock opened and closed at 0.79 Jordanian Dinars (JD), marking a notable deviation from its previous closing price of 0.
Stock prices
Gulf Pharmaceutical Industries, a key player on the Abu Dhabi Securities Exchange (ADX), witnessed a stable trading session on August 28, 2025, as its stock price remained unchanged throughout the day. The company's share price opened at 1.38 and closed at 1.37, reflecting a minor movement
Stock prices
The Saudi Exchange's Main Market witnessed substantial movement in the pharmaceutical sector, with key financial indicators revealing a notable shift in investor sentiments and the company's financial performance. As of August 27, 2025, the pharmaceutical company's share price closed at SAR 210.00, with
Drugs
President Trump has directed 17 major pharmaceutical companies to adopt a "most favored nation" policy, which would lower their U.S. prices by committing to international pricing parity. This move is part of an ongoing effort to address high prescription drug prices in the United States. Trump'
Drugs
U.S. President Donald Trump sent 17 letters to pharmaceutical companies' CEOs, threatening to take action if they do not lower drug prices within 60 days. The letters were sent after Trump signed an executive order in May to reinstate the "most favored nation" plan, which seeks
AstraZeneca PLC
AstraZeneca, Britain's most valuable public company, may be considering a move of its listing to the United States, a development that has raised concerns among government officials and industry experts. The company's plans to relocate its UK base from Cheshire to a new £1.1 billion
Free enterprise
President Donald Trump's new executive order aims to reduce prescription drug prices by addressing a meaningful area for change. The order focuses on a free market approach, which is uncommon in the second Trump administration. Trump has threatened consequences for companies that don't comply, and while
President of the United States
Donald Trump's administration is embracing policies typically associated with progressive Democrats, such as reducing soaring US drug prices, increasing taxes on the wealthy, and stricter enforcement of price-gouging laws. This shift comes as Trump's approval ratings drop due to his handling of the economy and the
President of the United States
The US imported a record $53 billion worth of pharmaceutical products and ingredients in March, a 160% increase from the same period last year, in anticipation of potential tariffs on the sector. This massive surge in imports underscores the impact of President Donald Trump's trade policies on global
Drugs
Donald Trump's latest executive order aims to reduce prescription drug prices in the US, but experts say it will not accomplish much. The order directs the HHS Secretary to come up with a plan to determine "most-favored-nation price targets" for pharmaceutical companies, but this is a
President of the United States
A longstanding issue in the US is the high prices of prescription pharmaceuticals, with the average cost being 2.8 times higher than in other OECD countries, including estimated discounts and rebates. President Trump has vowed to lower drug prices by as much as 80 percent, and his latest executive
Drugs
President Donald Trump signed an executive order aimed at pressuring pharmaceutical companies to align their U.S. pricing models with those in similarly wealthy countries. The "most-favored-nation" policy gives pharmaceutical companies 30 days to negotiate lower drug prices with the government. If no deal is reached, the US
